Precise Biometrics (PREC) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
13 Jun, 2025Executive summary
Net sales for Q2 2024 increased to SEK 20.6 million from SEK 17.9 million year-over-year, with positive momentum in both Biometric Technologies and Digital Identity segments.
EBITDA was positive for the third consecutive quarter, reaching SEK 0.1 million in Q2 and SEK 3.2 million for H1 2024, compared to negative results last year.
Operating loss narrowed to SEK -5.7 million in Q2 and SEK -8.5 million for H1, reflecting improved sales and product mix.
Annual Recurring Revenue (ARR) rose to SEK 18.6 million at period end, up from SEK 17.8 million year-over-year.
Significant events included new customer projects, product launches, and the appointment of a new CFO.
Financial highlights
Q2 net sales: SEK 20.6 million (+15.1% YoY); H1 net sales: SEK 42.3 million (+14.1% YoY).
Q2 EBITDA: SEK 0.1 million (Q2 2023: SEK -0.6 million); H1 EBITDA: SEK 3.2 million (H1 2023: SEK -1.2 million).
Q2 operating loss: SEK -5.7 million (Q2 2023: SEK -6.9 million); H1 operating loss: SEK -8.5 million (H1 2023: SEK -13.8 million).
Q2 gross margin: 71.4% (Q2 2023: 60.3%); H1 gross margin: 71.8% (H1 2023: 62.6%).
Cash and cash equivalents at period end: SEK 41.7 million (H1 2023: SEK 75.6 million).
Outlook and guidance
Several new customer projects are expected to generate revenue in H2 2024 and beyond.
Investments in marketing and sales are anticipated to drive future net sales growth.
The company expects continued growth in the mobile market and rising demand for biometric IT security solutions.
Strategic focus remains on increasing ARR and expanding market presence.
Latest events from Precise Biometrics
- Merger forms a global biometrics leader, targeting SEK 45 million in annual synergies by 2027.PREC
M&A announcement23 Mar 2026 - Positive EBITDA and cash flow achieved despite revenue decline and postponed customer volumes.PREC
Q4 202512 Feb 2026 - Positive EBITDA and stable ARR amid lower sales, with strong demand for biometric solutions.PREC
Q3 202514 Nov 2025 - Q2 saw stable sales and new biometric projects, but profitability was pressured by currency and customer shifts.PREC
Q2 202515 Aug 2025 - Q3 delivered strong growth, positive EBIT, and record margins, with robust outlook ahead.PREC
Q3 202413 Jun 2025 - Fifth straight quarter of growth and positive EBITDA, with strong outlook for 2025.PREC
Q4 20245 Jun 2025 - Net sales fell 7.7% in Q1 2025, but growth prospects remain strong for the year.PREC
Q1 20255 Jun 2025